← Back
Data updated: Mar 10, 2026
ARDELYX INC
Gastroenterology
ARDELYX INC is a pharmaceutical company focused on Gastroenterology. Key products include IBSRELA.
2019
Since
2
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
Recent Activity
XPHOZAH 2025-06-16
Labeling
IBSRELA 2025-05-20
Labeling
XPHOZAH 2025-03-21
Labeling
IBSRELA 2025-01-10
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 100%
0 drugs Phase 3: 2 Phase 2: 1
Pipeline Strength Pro
Loading...